Inogen, Inc. (INGN)
NASDAQ: INGN · Real-Time Price · USD
6.99
-0.04 (-0.57%)
At close: Nov 7, 2025, 4:00 PM EST
7.00
+0.01 (0.14%)
After-hours: Nov 7, 2025, 5:14 PM EST
Inogen Revenue
Inogen had revenue of $92.39M in the quarter ending September 30, 2025, with 4.00% growth. This brings the company's revenue in the last twelve months to $347.03M, up 4.68% year-over-year. In the year 2024, Inogen had annual revenue of $335.71M with 6.35% growth.
Revenue (ttm)
$347.03M
Revenue Growth
+4.68%
P/S Ratio
0.52
Revenue / Employee
$453,039
Employees
766
Market Cap
189.77M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 335.71M | 20.05M | 6.35% |
| Dec 31, 2023 | 315.66M | -61.58M | -16.32% |
| Dec 31, 2022 | 377.24M | 19.24M | 5.37% |
| Dec 31, 2021 | 358.00M | 49.52M | 16.05% |
| Dec 31, 2020 | 308.49M | -53.46M | -14.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
INGN News
- 3 days ago - Inogen, Inc. (INGN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Inogen Announces Third Quarter 2025 Financial Results - Business Wire
- 24 days ago - Inogen to Report Third Quarter 2025 Financial Results on November 5, 2025 - Business Wire
- 6 weeks ago - Inogen Announces the Appointment of Naga Rameswamy as Chief Technology Officer - Business Wire
- 3 months ago - Inogen, Inc. (INGN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Inogen Announces Second Quarter 2025 Financial Results - Business Wire
- 4 months ago - Inogen to Report Second Quarter 2025 Financial Results on August 7, 2025 - Business Wire
- 4 months ago - Inogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen Therapy - Business Wire